Biotech Startups
10,099 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
XCR Diagnostics develops portable molecular diagnostic systems for rapid nucleic acid testing at the point of care. The Pyramid system delivers lab-quality results in approximately 7 minutes for infectious disease detection in hospitals, clinics, emergency rooms, and resource-limited settings.
0 investors
XDemics develops cell culture and biomanufacturing technologies for generating mammalian cells at high densities for advanced therapy production. The company's HDCR platform and related products enable researchers and GMP facilities to produce T cell, stem cell, and viral-based therapies with improved quality and consistency.
0 investors
0 investors
0 investors
Xenetic Biosciences is a biopharmaceutical company developing immuno-oncology technologies for hard-to-treat cancers. Its DNase platform targets neutrophil extracellular traps (NETs) to improve existing treatments, with a systemic DNase program being advanced into the clinic as an adjunctive therapy for pancreatic carcinoma and other solid tumors.
0 investors
0 investors
XenoTherapeutics develops regenerative medicine therapies derived from genetically engineered pigs as a living donor source, aiming to replace human cadaver tissue. Its first product, realSKIN, is a living skin transplant intended to support healing after severe injury.
0 investors
0 investors
0 investors
Elpis Biopharmaceuticals is a clinical-stage biopharma company developing bispecific armored CAR-T cell therapies for solid tumors, addressing tumor heterogeneity and the immunosuppressive tumor microenvironment. Its pipeline includes EPC-003 for glioblastoma and EPC-002 for a range of solid tumors, built on proprietary armor, bispecific antibody, cell manufacturing, and mRNA display discovery platforms.
0 investors
0 investors
0 investors
0 investors
Xtressé sells hair growth products, including strawberry-flavored gummies with NAD+ and an X3-BioActive Blend, a dual-action Grow System, and an in-office concentrate treatment with growth factors available through authorized providers. The consumer wellness brand targets people experiencing hair thinning or hair loss.
0 investors
0 investors
Yatiri Bio applies unbiased proteomics, deep learning, and patient-derived cellular models to cancer drug discovery, building a molecularly defined patient landscape to identify ideal patient subsets for novel therapeutics. It offers computational tools such as its ProteoBrowser data portal and ProteoModels cellular systems for oncology drug developers working on personalized medicine.
0 investors
0 investors